Interesting Article from MDLinx

MDLinx  Psychiatry

5 minutes to stay current

Your Article Summary

Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: A 6-year, multinational, single-arm, open-label study
International Clinical Psychopharmacology, 06/02/14
McDonnell DP, et al. – The objective of this study was to assess the long–term safety and efficacy of olanzapine long–acting injection (LAI). Olanzapine LAI appeared effective as a long–term maintenance treatment, with a safety profile generally consistent with the known profile of oral olanzapine, except for injection–related events (including post–injection delirium/sedation syndrome).

>> Click here to see the complete list

No comments:

HOME (*Revenire-Pagina la Zi)